Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,758	2,749	3,206	1,095	1,121	324.57
Trading Asset Securities	-	-	-	-	26.06	27.45
Cash & Short-Term Investments	2,758	2,749	3,206	1,095	1,147	352.03
Cash Growth	-32.06%	-14.27%	192.71%	-4.49%	225.79%	-37.71%
Accounts Receivable	1,434	1,255	997.69	767.03	850.02	691.24
Other Receivables	5.29	11.8	8.32	6.46	5.72	8.52
Receivables	1,439	1,266	1,006	773.49	855.74	699.77
Inventory	1,654	1,929	1,959	2,021	1,682	1,170
Other Current Assets	118.25	127.5	142.55	102.87	87.38	73.69
Total Current Assets	5,968	6,071	6,314	3,993	3,772	2,295
Property, Plant & Equipment	4,190	4,274	3,722	3,144	2,645	2,321
Long-Term Investments	204.94	108.08	121.88	109.13	101.07	29.87
Goodwill	88.36	88.6	110.11	111.11	70.35	75.07
Other Intangible Assets	507.78	516.11	504.74	454.03	412.47	235.78
Long-Term Deferred Tax Assets	0.05	1.68	0.75	24.43	11.21	7.58
Long-Term Deferred Charges	71.54	64.76	73.2	69.07	16.21	0.14
Other Long-Term Assets	0.24	2.9	4.74	8.38	12.15	36.54
Total Assets	11,031	11,127	10,852	7,914	7,040	5,002
Accounts Payable	1,156	1,459	1,198	1,245	988.14	530.25
Accrued Expenses	112.46	202.63	227.81	201.85	168.05	149.82
Short-Term Debt	300.03	-	-	50.05	498.84	788.02
Current Portion of Long-Term Debt	107.05	201.93	7.77	200.21	-	10.01
Current Portion of Leases	-	7.79	6.78	6.59	1.01	-
Current Income Taxes Payable	80.3	55.74	55.3	78.8	75.37	26.86
Current Unearned Revenue	83.43	69.75	75.41	83.08	49.64	22.76
Other Current Liabilities	50.11	49.84	85.95	348.37	303.65	105.32
Total Current Liabilities	1,890	2,046	1,657	2,214	2,085	1,633
Long-Term Debt	-	194.25	389.05	83.99	201.49	140.19
Long-Term Leases	10.73	8.03	11.89	10.6	3.25	-
Long-Term Unearned Revenue	137.51	139.89	109.12	101.2	97.31	92.49
Long-Term Deferred Tax Liabilities	84.42	87.47	101.47	106.26	76.55	49.95
Other Long-Term Liabilities	42.07	41.76	50.77	25.76	-	-
Total Liabilities	2,164	2,518	2,319	2,542	2,463	1,916
Common Stock	895.24	895.24	899.49	834.25	832.6	805.23
Additional Paid-In Capital	4,380	4,380	4,499	2,058	1,985	971.34
Retained Earnings	3,600	3,350	3,190	2,515	1,802	1,335
Treasury Stock	-99.9	-99.9	-132.01	-113.12	-44.43	-30.66
Comprehensive Income & Other	18.61	11.52	4.65	2.26	1.49	2.54
Total Common Equity	8,794	8,537	8,461	5,297	4,577	3,083
Minority Interest	72.6	72.91	71.94	75.1	-	2.91
Shareholders' Equity	8,867	8,610	8,533	5,372	4,577	3,086
Total Liabilities & Equity	11,031	11,127	10,852	7,914	7,040	5,002
Total Debt	417.81	412	415.49	351.44	704.58	938.22
Net Cash (Debt)	2,340	2,337	2,791	743.98	442.29	-586.2
Net Cash Growth	-0.18%	-16.27%	275.13%	68.21%	-	-
Net Cash Per Share	2.64	2.62	3.13	0.90	0.53	-0.72
Filing Date Shares Outstanding	889.45	889.45	899.49	834.25	832.6	831.41
Total Common Shares Outstanding	889.45	889.45	899.49	834.25	832.6	805.23
Working Capital	4,079	4,025	4,658	1,779	1,687	662.34
Book Value Per Share	9.89	9.60	9.41	6.35	5.50	3.83
Tangible Book Value	8,198	7,932	7,846	4,732	4,094	2,772
Tangible Book Value Per Share	9.22	8.92	8.72	5.67	4.92	3.44
Buildings	-	1,966	1,786	1,612	1,562	1,354
Machinery	-	4,665	4,350	4,010	3,684	3,326
Construction In Progress	-	1,566	1,198	839.25	471.51	300.08

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.